Janine Marquez
@Rice Hall James & Associates, Llc
Latest period2024 - Q3ReportedManaged Assets$1.848BTotal holdings250
Assets growth rate10.84%Assets growth rate (2-Q avg)3.01%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Rice Hall James & Associates, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 250 positions.
Assets under management
The assets under management (AUM) of Rice Hall James & Associates, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.848B in assets, with a quarterly growth rate of 10.84% and a 2-quarter average growth rate of 3.01%. The portfolio is managed by Janine Marquez, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ASNDAscendis Pharma A S
| 1.3% | $23.981M 160,614 shares@ $149.31 avg price | Increased 5.91% |
FCFranklin Covey Co
| 1.23% | $22.586M 549,145 shares@ $41.14 avg price | Increased 9% |
RDWRRadware Ltd
| 1.13% | $20.757M 931,651 shares@ $22.28 avg price | Increased 6.41% |
TRAKRepositrak Inc
| 1.02% | $18.734M 1.014M shares@ $18.48 avg price | Increased 15.14% |
SSTKShutterstock Inc
| 1.02% | $18.724M 529,387 shares@ $35.37 avg price | Increased 40.71% |
SUPNSupernus Pharmaceuticals Inc
| 0.92% | $16.862M 540,788 shares@ $31.19 avg price | Increased 7.61% |
BCRXBiocryst Pharmaceuticals Inc
| 0.89% | $16.444M 2.164M shares@ $7.61 avg price | Increased 4.05% |
KNSAKiniksa Pharmaceuticals Intl
| 0.88% | $16.234M 649,630 shares@ $25.0 avg price | Increased 8.16% |
IOVAIovance Biotherapeutics Inc
| 0.86% | $15.767M 1.679M shares@ $9.39 avg price | Increased 2.64% |
CRAICra Intl Inc
| 0.83% | $15.16M 86,470 shares@ $175.32 avg price | Increased 17.89% |